Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;15(3):350-66.
doi: 10.1007/s11940-013-0229-6.

Chronic inflammatory demyelinating polyneuropathy

Mazen M Dimachkie  1 , Richard J Barohn
Affiliations

Chronic inflammatory demyelinating polyneuropathy

Mazen M Dimachkie et al. Curr Treat Options Neurol. 2013 Jun.

Abstract

Chronic Inflammatory polyneuropathies are an important group of neuromuscular disorders that present chronically and progress over more than 8 weeks, being referred to as chronic inflammatory demyelinating polyneuropathy (CIDP). Despite tremendous progress in elucidating disease pathogenesis, the exact triggering event remains unknown. Our knowledge regarding diagnosis and management of CIDP and its variants continues to expand, resulting in improved opportunities for identification and treatment. Most clinical neurologists will be involved in the management of patients with these disorders, and should be familiar with available therapies for CIDP. We review the distinctive clinical, laboratory, and electro-diagnostic features that aid in diagnosis. We emphasize the importance of clinical patterns that define treatment responsiveness and the most appropriate therapies in order to improve prognosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Mazen M. Dimachkie declares that he has no conflict of interest.

Richard J. Barohn declares that he has no conflict of interest.

References

    1. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10(3):222–6. - PubMed
    1. Barohn RJ. Approach to peripheral neuropathy and neuronopathy. Semin Neurol. 1998;18(1):7–18. - PubMed
    1. Khan S, Wolfe G, Nascimento O, Pasnoor M, et al. North American and South America (NA-SA) Neuropathy project (abstract) Neurology. 2006;66:A84. - PubMed
    1. Pasnoor M, Nascimento O, Trivedi J, Wolfe GI, Nations S, Herbelin L, et al. North America and South America (NA-SA) Neuropathy Project. International Journal of Neuroscience. 2013 doi: 10.3109/00207454.2013.782026. - DOI - PubMed
    1. Laughlin RS, Dyck PJ, Melton LJ, 3rd, Leibson C, Ransom J, Dyck PJ. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology. 2009;73(1):39–45. - PMC - PubMed

LinkOut - more resources